Search Results for: HOT MELT EXTRUSION OptiMelt Hot
Articles
August 31, 2015
HOT MELT EXTRUSION - OptiMelt™ Hot Melt Extrusion Technology to Improve Bioavailability of Poorly Soluble Drugs August 31, 2015
Sampada Upadhye, PhD, indicates bioavailability enhancement with formulation and dose form flexibility can be achieved through the application of HME technology to produce stable drug formulations and increased development success rates.
April 24, 2018
Catalent to Invest $5 Million at Somerset Site to Create New Drug Development & Modified Release Center of Excellence April 24, 2018
Catalent Pharma Solutions recently announced it plans to invest $5 million in the creation of a new drug development center...
November 14, 2014
Catalent Adds Global Particle Size Technology Leader to Industry’s Broadest Bioavailability & Delivery Technology Offerings November 14, 2014
Somerset, N.J. – November 13, 2014 — Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and...
October 16, 2013
SOLID DOSAGE FORMS - Better Treatments Through Innovative Solid Oral Drug Release Technologies October 16, 2013
Steven Hamlen, MBA, and Nicholas Johnson, PhD, MBA, discuss recent technology innovations in controlled-release solid oral dose functions and forms as well as more established methods for altering release profiles of molecules, and provide a real-world case study in which applying alternative formulation technology significantly improved an existing therapy and delivered patient and payer benefits.
September 30, 2013
Catalent Announces Expansion to Improve Bioavailability September 30, 2013
Catalent Pharma Solutions recently announced several advancements and expansion of its OptiMelt Hot Melt Extrusion (HME) capabilities in Somerset, NJ....
June 17, 2013
Catalent Pharma Solutions Breaks Ground on $35-Million Expansion for Controlled Release June 17, 2013
Catalent Pharma Solutions recently announced a major expansion of its controlled release drug manufacturing facility in Winchester, KY. The company...
April 8, 2012
4/10/2012 April 8, 2012
Catalent & BASF Join Forces to Solve Bioavailabilty Challenges Catalent Pharma Solutions and BASF recently announced they have entered into...
April 8, 2012
Catalent & BASF Join Forces to Solve Bioavailabilty Challenges April 8, 2012
Catalent Pharma Solutions and BASF recently announced they have entered into a broad collaboration and Open Alliance to provide solutions...
January 29, 2012
1/31/2012 January 29, 2012
Amgen to Buy Micromet for $1.16 Billion Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger...
January 29, 2012
Catalent Expands Controlled-Release Drug Development & Supply Capabilities January 29, 2012
Catalent Pharma Solutions recently announced it is continuing to expand its drug development and delivery capabilities to help customers bring...
